Table of contents of journal:

Results: 16

Aromatase inhibition: The outcome of 20 years of drug development

Authors: Dowsett, M

Citation: M. Dowsett, Aromatase inhibition: The outcome of 20 years of drug development, AROMATASE INHIBITION AND BREAST CANCER, 2001, pp. 3-15

Role of hormonal therapy and chemotherapy in advanced breast cancer: An overview

Authors: Harvey, HA Sachdeva, K

Citation: Ha. Harvey et K. Sachdeva, Role of hormonal therapy and chemotherapy in advanced breast cancer: An overview, AROMATASE INHIBITION AND BREAST CANCER, 2001, pp. 19-28

Place of aromatase inhibitors in the endocrine therapy of breast cancer

Authors: Johnston, SRD Smith, IE Dowsett, M

Citation: Srd. Johnston et al., Place of aromatase inhibitors in the endocrine therapy of breast cancer, AROMATASE INHIBITION AND BREAST CANCER, 2001, pp. 29-49

Clinical overview of aromatase inhibitors

Authors: Smith, IE

Citation: Ie. Smith, Clinical overview of aromatase inhibitors, AROMATASE INHIBITION AND BREAST CANCER, 2001, pp. 51-62

Who benefits most from second-line treatment with letrozole?

Authors: Wischnewsky, MB Schmid, P Possinger, K Bohm, R Chaudry, HA

Citation: Mb. Wischnewsky et al., Who benefits most from second-line treatment with letrozole?, AROMATASE INHIBITION AND BREAST CANCER, 2001, pp. 63-84

Neoadjuvant endocrine therapy

Authors: Dixon, JM

Citation: Jm. Dixon, Neoadjuvant endocrine therapy, AROMATASE INHIBITION AND BREAST CANCER, 2001, pp. 103-116

Adjuvant endocrine therapy

Authors: Mouridsen, HT

Citation: Ht. Mouridsen, Adjuvant endocrine therapy, AROMATASE INHIBITION AND BREAST CANCER, 2001, pp. 117-129

Health economics aspects of endocrine therapy

Authors: Wait, S

Citation: S. Wait, Health economics aspects of endocrine therapy, AROMATASE INHIBITION AND BREAST CANCER, 2001, pp. 143-154

Chemoprevention with aromatase inhibitors

Authors: Goss, PE

Citation: Pe. Goss, Chemoprevention with aromatase inhibitors, AROMATASE INHIBITION AND BREAST CANCER, 2001, pp. 161-181

Immunohistochemistry of aromatase: A recent new development

Authors: Sasano, H Suzuki, T Moriya, T

Citation: H. Sasano et al., Immunohistochemistry of aromatase: A recent new development, AROMATASE INHIBITION AND BREAST CANCER, 2001, pp. 191-198

Molecular epidemiology of aromatase expression in 1182 primary breast cancers

Authors: Eppenberger, U Levano, S Schoumacher, F Muller, H Eppenberger-Castori, S Evans, D

Citation: U. Eppenberger et al., Molecular epidemiology of aromatase expression in 1182 primary breast cancers, AROMATASE INHIBITION AND BREAST CANCER, 2001, pp. 199-212

Induction and suppression of aromatase by inhibitors

Authors: Miller, WR Vidya, R Mullen, P Dixon, JM

Citation: Wr. Miller et al., Induction and suppression of aromatase by inhibitors, AROMATASE INHIBITION AND BREAST CANCER, 2001, pp. 213-225

Relevance of animal models to the clinical setting

Authors: Brodie, AMH Long, B Lu, Q Liu, Y

Citation: Amh. Brodie et al., Relevance of animal models to the clinical setting, AROMATASE INHIBITION AND BREAST CANCER, 2001, pp. 227-241

Aromatase inhibitors as therapy for pubertal gynecomastia

Authors: Kaplowitz, PB

Citation: Pb. Kaplowitz, Aromatase inhibitors as therapy for pubertal gynecomastia, AROMATASE INHIBITION AND BREAST CANCER, 2001, pp. 259-266

Aromatase inhibition and prostate cancer

Authors: Smith, MR

Citation: Mr. Smith, Aromatase inhibition and prostate cancer, AROMATASE INHIBITION AND BREAST CANCER, 2001, pp. 271-276

Aromatase in endometriosis: Biological and clinical application

Authors: Bulun, SE Zeitoun, KM Takayama, K Sasano, H Simpson, ER

Citation: Se. Bulun et al., Aromatase in endometriosis: Biological and clinical application, AROMATASE INHIBITION AND BREAST CANCER, 2001, pp. 279-291

Risultati: 1-16 |